Hengrui Pharmaceutical announced that on October 19, 2026, the company repurchased 203,600 A-shares through the Shanghai Stock Exchange, accounting for 0.003% of the shares issued before the incident. The repurchase price range was 46.08 yuan to 46.21 yuan per share, with a total transaction amount of about 9.408 million yuan. The purchased shares are intended to be used for A-share employees' shareholding plans and will be held as treasury shares. As of October 19, 2026, the number of shares in the company's treasury was 12,917,450 shares, and the total number of issued shares was 6,379,002,274 shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.